FDA Enforcement Class II Ongoing

PrisMax System, Product Codes: a) 955558, b) 955627, c) 955701

Recall: Z-0993-2022 · Reported May 4, 2022

Enforcement

Recall Number
Z-0993-2022
Event ID
89823
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Baxter Healthcare Corporation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
May 4, 2022
Initiation Date
March 15, 2022
Classification Date
April 22, 2022
Address
1 Baxter Pkwy, Deerfield, IL, 60015-4625, United States

Description

PrisMax System, Product Codes: a) 955558, b) 955627, c) 955701

Reason

This correction is due to software anomalies occurring during use. If the operator initiates therapy by entering a value other than the default value for the patient Gain/Loss Limit or the Return Pressure Drop Limit (RDL) and uses the Same Patient function, the PrisMax System will return the patient Gain/Loss Limit or the RDL to the default value, rather than the non-default value entered at the initiation of treatment. The PrisMax System interface will display the original values once treatment is restarted but does not have an alert to inform the user of the change. The RDL value will be returned to the original value immediately upon selecting the Same Patient function. The Gain/Loss Limit value will be returned to the original value when the patient weight and/or hematocrit is changed during treatment.

Code Info

a) 955558, UDI 07332414124359, b) 955627, UDI 07332414124700, c) 955701, UDI 07332414125844, All Serial Numbers

Distribution

Worldwide distribution - US Nationwide and the countries of Mexico, Brazil, Jamaica, Trinidad and Tobago, Canada, Australia, Singapore, Hong Kong, Vietnam, New Zealand, Korea, Austria, Belgium, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Israel, Italy, Luxemburg, Netherlands, Norway, Poland, Portugal, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, and United Kingdom.

Quantity

3513 units